- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Fund Finance
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Leveraged Finance
- Mergers and Acquisitions (M&A)
- Middle East and Islamic Finance and Investment
- Private Credit & Special Situations
- Private Equity
- Public Companies
- Real Estate
- Structured Finance and Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- Innovation Protection
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Antitrust
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Innovation Protection
- Intellectual Property
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy Transition
- Energy
- Financial Services
- Food and Beverage
- Higher Education
- Life Sciences and Healthcare
- Technology
- Artificial Intelligence (AI) and Machine Learning
- Buy American
- Crisis Management
- Doing Business in Latin America
- Environmental Agenda
- Environmental, Social and Governance (ESG)
- Focus on Women's Health
- Institutional Culture and Sensitive Investigations
- Russia/Ukraine
- Special Purpose Acquisition Companies (SPACs)
- Careers
- News & Insights
- About
- Languages
Brandt Leibe
Events 16 results
Webinar
May 8, 2025
Fraud Enforcement in the Trump Administration and Strategies to Mitigate Risk
Webinar
April 29, 2025
FCA Enforcement and Litigation: How Recent Decisions and Policy Announcements Signal Key Changes
Speaking Engagement
February 26, 2025
Brandt Leibe and Michael Galdo to Speak at ACAMS Central Texas Chapter
Conference
September 5, 2024
17th Annual King & Spalding Medical Device Summit
Conference
November 7, 2023
Pharmaceutical University 2023
Speaking Engagement
January 25, 2023
Bill Gordon, Brandt Leibe to Speak at 16th Forum on the Foreign Corrupt Practices Act Houston
Conference
November 1, 2022
Pharmaceutical University 2022
Conference
October 27, 2022
Energy Forum: Update on the Energy Sector in Mexico and Colombia – What’s Next
Conference
June 21, 2018
West Coast Pharmaceutical & Medical Device University
Conference
November 15, 2016
9th Annual King & Spalding Pharmaceutical University
Conference
September 29, 2016
King & Spalding Energy Forum: Winds of Change in Latin America
Conference
April 7, 2016
West Coast Pharma & Medical Device University